The toxicity of 3'-azidothymidine (AZT) in human lymphocytes has been shown previously to be reversed by co-incubation with the ribonucleosides cytidine or uridine. In the present paper, the effects of 3' -azidothymidine and cytidine/uridine, both alone and in combination, were studied upon key processes in lymphocytes in order to discover more about the mechanism of toxicity reversal.
Introduction
3' -Azido-3'-deoxythymidine (AZl) is a thymidine analogue with potent anti-human immunodeficiency virus (HIV) activity in vitro (Mitsuya et al., 1985) . It is phosphorylated intracellularly by the thymidine salvage pathway and, as the triphosphate, inhibits the reverse transcriptase (Rl) of HIV with chain termination (Mitsuya et al., 1985; Furman et al., 1986) . Although AZT has proven efficacy , its usefulness is limited by its toxic side-effects. These are severe enough to require dosage reduction or discontinuation for a substantial number of patients . The reduction or removal of the toxic side effects would enhance considerably the clinical benefit of AZT.
However, the precise mechanism of toxicity of AZT remains unclear. It has been assumed that AZT triphosphate interferes with cellular DNA metabolism in some way, although the mechanism by which it does so is not clear. AZT triphosphate is a poor inhibitor of cellular or mitochondrial DNA polymerase (Furman et el., 1986; Simpson et al., 1989) . None of the metabolites of AZT strongly inhibit either ribonucleotide reductase or thymidylate synthase (Balzarini et al., 1988; Dzik et al., 1988; Harrington et al., 1987) .AZT does inhibit thymidine kinase (Balzarini et al., 1988) and thymidylate kinase (Furman et aI., 1986) , and the toxicity was therefore at first thought to be owing to a paucity of TIP (Furman et al., 1986) .
However, later studies have shown that the AZTinduced perturbations in dNTP pools are only temporary and vary according to the type of cells examined (Frick et al., 1988; Frick and Nelson, 1989 ). Furthermore, it has been shown previously that co-incubation with non-toxic concentrations of thymidine does not decrease the toxicity of AZT, but instead increases it, despite enlarging the TIP pool and reducing the phosphorylation of AZT . These factors suggest that AZT has a limited effect on cellular DNA metabolism and that this does not account wholly for the toxicity, at least in cell culture. This is supported by observations that AZT toxicity can be reversed by cytidine and uridine, which, being ribonucleosides, do not have any direct effect upon DNA metabolism but instead point to the involvement of RNA metabolism in AZT toxicity (Sommadossi et al., 1988; Cox and Harmenberg, 1990 ). Furthermore, we have shown that co-incubation with non-toxic concentrations of other nucleosides (adenosine, deoxyadenosine, guanosine, deoxyguanosine, deoxycytidine, and deoxyuridine) increases the toxicity of AZT, which suggests that AZT may have some general effect upon nucleoside metabolism . The elucidation of the biochemical basis for the reversal of AZT toxicity by cytidine and uridine, and its potentiation by other nucleosides, would further our understanding of the mechanism of toxicity of AZT. We therefore decided to investigate further the effects of AZT upon human lymphocytes and the nature of the reversal of toxicity of cytidine and uridine. Ribonucleoside triphosphate pools, intracellular and extracellular nucleoside pools, and the intracellular pools of AZT were examined in the presence of AZT alone or in combination with cytidine and uridine. The effect of nucleobases upon AZT toxicity was determined.
Results

Effects upon rNTP pools
The effects of AZT, cytidine and uridine, both alone and in combination, upon the rNTP pools of lymphocytes are shown in Table 1 . Incubation with AZT caused a slight rise in the UTPand ATP pools (P < 0.005) but otherwise did not significantly affect the rNTP pools of lymphocytes. In comparison with untreated cells, incubation with cytidine alone caused the CTP pools to increase 75-fold (P < 0.001). A similar rise in CTP, and a reduction in the UTP pool. were seen when cells were treated with cytidine in combination with AZT (P < 0.001). Uridine caused the UTP pool to double and theATP and GTPpools to fall to about half (P < 0.001). When uridine was combined with AZT, similar effects were seen, but in addition the CTP pool was doubled (P = 0.005).
Effects upon intracellular and extracellular nucleoside pools
The intracellular and extracellular pools of nucleosides in cells treated with AZT are shown in Table 2 . No intracellular or extracellular nucleosides could be detected in untreated cells. Incubation with AZT caused the appearance of thymidine in the medium of treated cells. Co-incubation with uridine reduced the AZT-induced extracellular thymidine pool to half, while co-incubation with thymidine increased it fourfold (P < 0.001).
Cells treated with cytidine alone contained larger intracellular pools of both cytidine and uridine than extracellular pools (P < 0.001). Co-incubation with cytidine and AZT increased still further the intracellular cytidine and uridine pools compared to incubation with cytidine alone (P < 0.005). Cells treated with uridine alone had a larqe intracellular pool of uridine and a small extracellular uridine pool. Co-incubation with uridine and AZT increased the I Reversal of azidothymidine toxicity 25
Discussion
The reversal of AZT toxicity by the ribonucleosides cytidine and uridine (Sommadossi et al., 1988; Cox and Harmenberg, 1990) is an interesting phenomenon which points to the involvement of RNA metabolism in AZT toxicity. In order to discover more about the mechanism of toxicity reversal we have examined the effects of toxic concentrations of AZT. in the presence and absence of cytidine and uridine, upon ribonucleoside metabolism in lymphocytes. Incubation with a toxic concentration of AZT caused only minor alterations in the rNTP pools of lymphocytes. Co-incubation with AZT and cytidine or uridine caused similar alterations in the rNTP pools when compared to incubation with cytidine or uridine alone. The small differences seen are unlikely to have a major effect upon RNA metabolism. It therefore appears thatAZT has only minor effects upon the rNTP pools of lymphocytes, and the ability of cytidine and uridine to reverse AZT toxicity does not seem to be related to the correction of large deficiencies in the rNTP pools. AZT has been shown to enter cells by passive diffusion across the membrane and not by the nucleoside transporter which is responsible for the transport of natural nucleosides (Zimmerman et al., 1987) . Nucleosides would therefore not be expected to affect the uptake of AZT, and in fact neither cytidine, uridine nor thymidine had any effect on the intracellular pool of AZT. The reversal of AZT toxicity by cytidine and uridine is therefore unlikely to be owing to the blocking of AZT uptake by these nucleosides. However, AZT might have effects on the uptake of normal nucleosides, causing imbalances in nucleoside pools which cytidine and uridine might be capable of correcting. The effect of AZT upon intracellular and extracellular nucleoside pools was therefore determined.
Treatment of cells with AZT caused the excretion of thymidine from CEM lymphocytes. This has also been noted in other cell types (Frick et al., 1988) and probably results from the inhibition of thymidine kinase and thymidylate kinase by AZT. No other nucleosides were excreted by AZT-treated cells. Neither thymidine nor any other natural nucleoside could be detected intracellularly in AZT-treated cells. Since thymidine is excreted by AZT-treated cells, some intracellular thymidine can be expected to exist, but this must have been below the limit of detection.
the absence and presence of various non-toxic concentrations of bases and xanthosine. Co-incubation with adenine, guanine, uracil, hypoxanthine and xanthosine all increased the toxicity of AZT compared to AZT alone. Co-incubation with dihydrouracil, thymine and xanthine did not affect the toxicity of AZT (data not shown). 
Effect of nucleoacidbases upon AZT toxicity
The effect of various nucleoacidbases upon the toxicity of AZTwas determined. Figure 1 shows the toxicity of AZT in
Effects upon intracellular AZT pools
The intracellular pools of AZT in the absence and presence of nucleosides were measured using RIA. In the absence of nucleosides the intracellular concentration of AZT was 2.2 J.LM. Co-incubation with cytidine, uridine or thymidine did not significantly affect the intracellular AZT pools (intracellular concentrations were 2.3 J.LM, 1.8 J.LM and 2.4 J.LM, respectively, P> 0.05). intracellular uridine pool and caused the appearance of an intracellular cytidine pool (P < 0.001).
Cells incubated with thymidine had a small extracellular thymidine pool but no measurable intracellular pool of thymidine. Co-incubation with thymidine and AZT caused the appearance of intracellular cytidine and uridine pools.
Cytidine and uridine were consistently found in higher concentrations intracellularly than extracellularly, whilst the reverse was true for thymidine.
Co-incubation with AZT raised the intracellular pools of cytidine and uridine compared to incubation with cytidine or uridine alone. The reason for this AZT-induced increase in intracellular cytidine and uridine pools is not yet clear. AZT could interfere with some aspect of the metabolism and/or breakdown of cytidine and uridine, although AZT did not appear to interfere with the formation of CTP or UTP. Alternatively, AZT could affect the transport of cytidine and uridine. Incubation with AZT alone did not appear to increase the intracellular pools in the absence of exogenous cytidine or uridine, although we cannot rule out the possibility that changes occurred which were below the limit of detection. Furthermore, the intracellular cytidine and uridine pools were increased by AZT when combined with thymidine, where increased uptake of extracellular cytidine or uridine is not possible.
An unequal distribution of nucleosides across the membrane was observed. The intracellular pools of cytidine and uridine were larger than the extracellular pools, while the reverse was true for thymidine. These results are not consistent with the transport of nucleosides by a facilitated diffusion mechanism, as has been proposed (Plagemann and Wohlhueter, 1980) . A sodiurn-dependent, concentrative transport mechanism has been shown to operate in cultured mouse T cells (Darnowski et al., 1987; Jakobs and Paterson, 1986) . It would appear from these results that a similar concentrative transport may also occur in cultured T cells of human origin.
The toxicity of AZT has been shown to be increased by co-incubation with several different nucleosides . This could indicate a general effect of AZT upon nucleoside breakdown. The toxicity of AZT in the presence of various bases was therefore examined in order to determine whether the toxic effects of AZT were related to the breakdown of nucleosides. Pyrimidine nucleosides are broken down via the bases thymine and dihydrouracil, whilst purine nucleosides are broken down via the individual bases to xanthine and then to uric acid by xanthine oxidase. Co-incubation with thymine, dihydrouracil or xanthine did not affect the toxicity of AZT (data not shown), whereas co-incubation with adenine, guanine, hypoxanthine and uracil increased the toxicity of AZT. Adenine, guanine and hypoxanthine can be anabolized intracellularly by phosphoribosyltransferases, forming the corresponding nucleosides, which have been shown to increase the toxicity of AZT .
These results indicate that AZT may have an effect on purine but not pyrimidine breakdown. The increased toxicity of AZT in combination with uracil is noteworthy, since the corresponding nucleoside (uridine) reverses the toxicity of AZT.
In conclusion, the reversal of AZT toxicity by cytidine and uridine in lymphocytes was not owing to the replacement of depleted rNTP pools or the prevention of uptake of AZT. AZT caused the intracellular pools of cytidine and uridine to increase, suggesting that AZT may affect either the uptake of cytidine and uridine or some aspect of their metabolism (other than the provision of rNTPs). Cytidine and uridine nucleotides are known to be involved in biochemical pathways other than RNA metabolism such as sugar and lipid metabolism, and nucleoside analogues such as bromovinyldeoxyuridine are known to interfere with the use of sugar nucleotides in glycosylation reactions (Olofsson et al., 1988; Olofsson and Datema, 1990) . This aspect of cytidine and uridine metabolism may be involved in the reversal of AZT toxicity and therefore deserves further investigation.
Materials and Experimental procedures
Abbreviations AIDS, acquired immunodeficiency syndrome; AZT, 3'-azido-3'deoxythymidine; HIV, human immunodeficiency virus; HPLC, high-performance liquid chromatography; RIA, radioimmunoassay; rNTP, ribonucleoside triphosphate.
Chemicals
Nucleosides, nucleotides and bases were of the highest purity available and were purchased from Sigma Chemical Co. (St Louis, MO).
Cell culture
CEM cells (a human CD4+ lymphocyte cell line) were grown in RPMI medium with 10% foetal calf serum and antibiotics at 37°C in a humidified atmosphere of 5% CO 2 in air. Cell counting and viability were determined by the trypan blue exclusion method. For experiments on rNTP and nucleoside pool sizes, cells (3 x 10 5/ml) were incubated with an approximately 40% growth inhibitory concentration of AZT (100 fLM) with and without the given concentration of nucleoside. This concentration of AZTwas chosen so that the toxic effect would be clearly seen but so that the cells would not be completely static. The concentrations of nucleosides used were the highest which did not themselves cause toxicity to the cells. After incubation at 3JOC for 72 h the cells were harvested by centrifugation, completely drained, and extracted in 6% cold trichloroacetic acid. The cells were not washed since this is known to reduce intracellular nucleosides. The cells were incubated on ice for 10min and the precipitate removed by centrifugation. The supernatant was neutralized by the amine-freon method (Chen et a/., 1977) . This method of preparing cell extracts has previously been shown to give excellent recovery of nucleotides (Harmenberg et el., 1990) . Nucleosides and nucleotides in the extract were then measured by HPLC analysis. AZT was measured by radioimmunoassay (RIA).
For experiments on the toxicity of AZT in combination with bases, cells were seeded in 24-well microtitre plates (2 x 10 5 cells well-1 ) with 100fLMAZT, in the presence and absence of bases.
The concentration of bases used were the highest which did not themselves cause toxicity. Control cells were incubated with the bases alone and served as the control when measuring the amount of AZT induced inhibition of cell growth. After 72 h cell growth was measured in a volume distribution analyser (Analysinstrurnent AB, Stockholm, Sweden).
HPLC analysis
All analyses were performed on a Waters chromatrograph equipped with a dual wavelength detector (254 and 280 nm) and a Shimadzu C-R3A integrator. Analysis of rNTP pools was performed on a 0.4 x 25 cm partisil 10 SM ion exchange column (Whatman, Clifton, NJ) using 0.5 MK H 2 P0 4 , adjusted to pH 3.5 at 2 ml rnln", as the eluting solvent. Nucleosides were analysed by reverse-phase HPLC on a 1 x 10 cm Novapak C18 column using 10mM sodium acetate (adjusted to pH 4.7) with 5% acetonitrile at 2ml rnin" as the eluting solvent. Prior to HPLC analysis the nucleosides in the cell medium were partly purified and concentrated by retention on a small C18 reverse-phase cartridge followed by elution with methanol and lyophilization. Nucleosides and nucleotides were identified by (i) retention time; (Ii) absorbance at 280nm: absorbance at 254nm and (iii) spiking with known standards.
AZTRIA
The AZT content of cell extracts and media was measured by competitive radioimmunoassay (RIA) as described previously .
Analysis of results
All experiments were performed in duplicate or triplicate. Results were analysed using the Student's t-test.
